Skip to content

Clinical trials

Phase 3 Leukemia, Promyelocytic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Promyelocytic, Acute Phase: Phase 3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20051
20061
20072
20091
20162
20191
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status7
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Groupe d'etude et de travail sur les leucemies aigues promyelocytaires2
Assistance Publique - Hôpitaux de Paris1
Associazione Italiana Ematologia Oncologia Pediatrica1
Eastern Cooperative Oncology Group1
European Organisation for Research and Treatment of Cancer - EORTC1
First Affiliated Hospital Xi'an Jiaotong University1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Medical Research Council1
National Cancer Institute (NCI)1
Peking University People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Promyelocytic, Acute16
Leukemia8
Leukemia, Erythroblastic, Acute3
Leukemia, Megakaryoblastic, Acute3
Leukemia, Monocytic, Acute3
Leukemia, Myeloid, Acute3
Leukemia, Myelomonocytic, Acute3
Congenital Abnormalities1
Hematologic Diseases1
Hematologic Neoplasms1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.